전남대학교 중앙도서관

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

issue: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E23.
Author: Kemp SA; Division of Infection and Immunity, University College London, London, UK.
Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Jahun A; Department of Pathology, University of Cambridge, Cambridge, UK.
Hosmillo M; Department of Pathology, University of Cambridge, Cambridge, UK.
Rees-Spear C; Division of Infection and Immunity, University College London, London, UK.
Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK.
Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK.
Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Canterbury, UK.
Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Blane E; Department of Medicine, University of Cambridge, Cambridge, UK.
Modis Y; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Leigh KE; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Briggs JAG; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Bioresource, Cambridge, UK.
Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; FES-Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico.
Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA.
Goldstein RA; Division of Infection and Immunity, University College London, London, UK.
Smielewska A; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK.
Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge, UK.
Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Illingworth CJR; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
McCoy LE; Division of Infection and Immunity, University College London, London, UK.
Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (Nature) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom.

학술저널

issue: Clinical trials (London, England) [Clin Trials] 2021 Oct; Vol. 18 (5), pp. 615-621. Date of Electronic Publication: 2021 Jun 22.
Author: Török ME; Department of Medicine, University of Cambridge, Cambridge, UK.; Departments of Infectious Diseases & Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK.
Underwood BR; Windsor Research Unit, Fulbourn Hospital, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.; Gnodde Goldman Sachs Translational Neuroscience Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Toshner M; Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Respiratory Medicine, Royal Papworth Hospital, Cambridge, UK.
Waddington C; Department of Medicine, University of Cambridge, Cambridge, UK.; Departments of Infectious Diseases & Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Sidhom E; Windsor Research Unit, Fulbourn Hospital, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.; Gnodde Goldman Sachs Translational Neuroscience Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Sharrocks K; Departments of Infectious Diseases & Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK.
Bousfield R; Departments of Infectious Diseases & Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK.
Summers C; Department of Medicine, University of Cambridge, Cambridge, UK.; John V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Saunders C; NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
McIntyre Z; Office for Translational Research, University of Cambridge, Cambridge, UK.
Morris H; NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Piper J; NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Calderon G; Windsor Research Unit, Fulbourn Hospital, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Dennis S; Department of Respiratory Medicine, Royal Papworth Hospital, Cambridge, UK.
Assari T; Research & Development Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
de Rotrou AM; Office for Translational Research, University of Cambridge, Cambridge, UK.
Shaw A; Medical Director's Office, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Bradley J; Department of Medicine, University of Cambridge, Cambridge, UK.; Research & Development Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
O'Brien J; Gnodde Goldman Sachs Translational Neuroscience Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Rintoul RC; Department of Respiratory Medicine, Royal Papworth Hospital, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK.
Smith I; Department of Respiratory Medicine, Royal Papworth Hospital, Cambridge, UK.
Bullmore E; Gnodde Goldman Sachs Translational Neuroscience Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Chatterjee K; NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
DB Label: Database : MEDLINE

원문보기: 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

SARS-CoV-2 evolution during treatment of chronic infection.

학술저널

issue: Nature [Nature] 2021 Apr; Vol. 592 (7853), pp. 277-282. Date of Electronic Publication: 2021 Feb 05.
Author: Kemp SA; Division of Infection and Immunity, University College London, London, UK.
Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Jahun A; Department of Pathology, University of Cambridge, Cambridge, UK.
Hosmillo M; Department of Pathology, University of Cambridge, Cambridge, UK.
Rees-Spear C; Division of Infection and Immunity, University College London, London, UK.
Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK.
Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK.
Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Canterbury, UK.
Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Blane E; Department of Medicine, University of Cambridge, Cambridge, UK.
Modis Y; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Leigh KE; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Briggs JAG; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Bioresource, Cambridge, UK.
Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; FES-Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico.
Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA.
Goldstein RA; Division of Infection and Immunity, University College London, London, UK.
Smielewska A; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK.
Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge, UK.
Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Illingworth CJR; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
McCoy LE; Division of Infection and Immunity, University College London, London, UK.
Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (Nature) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Rebooting medical education with virtual grand rounds during the COVID-19 pandemic.

학술저널

issue: Future healthcare journal [Future Healthc J] 2021 Mar; Vol. 8 (1), pp. e11-e14.
Author: Sparkes D; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; These authors contributed equally.
Leong C; Cambridge University Hospitals NHS Foundation Trust, Cambridge, Uk.; These authors contributed equally.
Sharrocks K; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Wilson M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Moore E; Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Matheson NJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, UK, honorary consultant in infectious diseases at Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK and honorary consultant in virology at NHS Blood and Transplant, Cambridge, UK.
DB Label: Database : MEDLINE

원문보기: Open Access (PubMed Central) Full Text (ScienceDirect O/A)

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation.

issue: MedRxiv : the preprint server for health sciences [medRxiv] 2020 Dec 29. Date of Electronic Publication: 2020 Dec 29.
Author: Kemp SA; Division of Infection and Immunity, University College London, London, UK.
Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Datir R; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Ferreira I; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Jahun A; Department of Pathology, University of Cambridge, Cambridge.
Hosmillo M; Department of Pathology, University of Cambridge, Cambridge.
Rees-Spear C; Division of Infection and Immunity, University College London, London, UK.
Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, UK.
Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, UK.
Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, UK.
Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Blane E; Department of Medicine, University of Cambridge, Cambridge, UK.
Briggs J; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
van GM; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Smith K; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Clinical Research Facility, Cambridge, UK.
Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust.
Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital.
Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital.
Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital.
Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Goldstein RA; Division of Infection and Immunity, University College London, London, UK.
Smielewska A; Department of Pathology, University of Cambridge, Cambridge.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust.
Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrookes' Hospital, Cambridge, UK.
Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge.
Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Illingworth C; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
McCoy LE; Division of Infection and Immunity, University College London, London, UK.
Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Africa Health Research Institute, Durban, South Africa.
DB Label: Database : MEDLINE

Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study.

학술저널

issue: Cell reports. Medicine [Cell Rep Med] 2020 Aug 25; Vol. 1 (5), pp. 100062. Date of Electronic Publication: 2020 Jul 15.
Author: Collier DA; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.
Assennato SM; Diagnostics for the Real World EU, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
Warne B; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
Sithole N; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Ritchie A; Diagnostics for the Real World EU, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
Ravji P; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Routledge M; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Sparkes D; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Skittrall J; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Smielewska A; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Ramsey I; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Goel N; Diagnostics for the Real World EU, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
Curran M; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge CB2 0QQ, UK.
Enoch D; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge CB2 0QQ, UK.
Tassell R; POC Testing, Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Lineham M; POC Testing, Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Vaghela D; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Leong C; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Mok HP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Bradley J; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.; National Institutes for Health Research (NIHR) Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
Mendoza V; NIHR Cambridge Clinical Research Facility, Cambridge CB2 0QQ, UK.
Demiris N; Department of Statistics, Athens University of Economics and Business, 28is Oktovriou 76, 104 34 Athens, Greece.
Besser M; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Dougan G; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
Lehner PJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
Siedner MJ; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Zhang H; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge CB2 0QQ, UK.
Waddington CS; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
Lee H; Diagnostics for the Real World EU, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.; Africa Health Research Institute, Durban 4001, South Africa.
DB Label: Database : MEDLINE

원문보기: Full Text (Clinical Key) Open Access (PubMed Central) Full Text (ScienceDirect O/A) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication.

학술저널

issue: Nature immunology [Nat Immunol] 2007 Jun; Vol. 8 (6), pp. 569-77. Date of Electronic Publication: 2007 May 13.
Author: Hodges A; Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK.
Sharrocks K
Edelmann M
Baban D
Moris A
Schwartz O
Drakesmith H
Davies K
Kessler B
McMichael A
Simmons A
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

1 2

바구니보기

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택